Journals / Journal of Clinical Research in Pediatric Endocrinology / 2016 / Cilt: 8 - Sayı: 2

Homozygous Ala65Pro Mutation with V89L Polymorphism in SRD5A2 Deficiency

Pages
218–223
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Identification of this mutation and polymorphism is a significant indicator of presence of 5αRD2 deficiency in Southeastern Turkey, a geographical region where consanguineous marriages are also highly common.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Deficiency of steroid 5-alpha reductase type 2 (5αRD2) is a rare autosomal recessive disorder caused by mutations in the SRD5A2 gene.
📊
Key Findings & Data:A defect in the 5-alpha reductase enzyme, which ensures conversion of testosterone into dihydrotestosterone, leads to disorders of sex development.
💡
Conclusion & Impact:Conclusion: Identification of this mutation and polymorphism is a significant indicator of presence of 5αRD2 deficiency in Southeastern Turkey, a geographical region where consanguineous marriages are also highly common.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Deficiency of steroid 5-alpha reductase type 2 (5αRD2) is a rare autosomal recessive disorder caused by mutations in the SRD5A2 gene. A defect in the 5-alpha reductase enzyme, which ensures conversion of testosterone into dihydrotestosterone, leads to disorders of sex development. This study presents the clinical and genetic results of patients with 5αRD2 deficiency. Methods: 5αRD2 deficiency was detected in 6 different patients from 3 unrelated families. All patients were reared as girls. Two of the patients presented with primary amenorrhea, one with primary amenorrhea and rejection of female gender, and the others with masses in their inguinal canals. Chromosome and sex-determining region Y (SRY) gene analyses were performed in all patients. Additionally, five exons of the SRD5A2 gene were amplified with polymerase chain reaction in the obtained DNA samples and evaluated. Results: While 46,XY was identified in 5 patients, 47,XXY was detected in one patient. The SRY gene was positive in all patients. The p.Ala65Pro (c193G>C) mutation and V89L polymorphism were observed in exon 1 of the SRD5A2 gene in all patients. Conclusion: Identification of this mutation and polymorphism is a significant indicator of presence of 5αRD2 deficiency in Southeastern Turkey, a geographical region where consanguineous marriages are also highly common.

🔖

Cite This Article

EREN, E., EDGÜNLÜ, T., ASUT, E., ÇELİK, S. K. (2016). Homozygous Ala65Pro Mutation with V89L Polymorphism in SRD5A2 Deficiency. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 8 - Sayı: 2, 218–223. https://ajindex.com/articles/214975

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol 2002;198:51-59
  2. Cheon CK. Practical approach to steroid 5 alpha-reductase type 2 deficiency. Eur J Pediatr 2011;170:1-8. Epub 2010 Mar 28 3. van Gils CH, Onland-Moret NC, Roest M, van Noord PA, Peeters PH. The V89L polymorphism in the 5-alphareductase type 2 gene and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1194-1199
  3. Ko JM, Cheon CK, Kim GH, Kim SH, Kim KS, Yoo HW. Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5alpha-reductase type 2 deficiency. Horm Res Paediatr 2010;73:41-48. Epub 2010 Jan 15 5. Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 1974;291:944-999
  4. Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 1991;354:159-161
  5. Thigpen AE, Davis DL, Milatovich A, Mendonca BB, ImperatoMcGinley J, Griffin JE, Francke U, Wilson JD, Russell DW. Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 1992;90:799-809
  6. Li Q, Zhu Y, He J, Wang M, Zhu M, Shi T, Qiu L, Ye D, Wei Q. Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a metaanalysis. Mol Biol Rep 2013;40:3597-3608. Epub 2013 Jan 1 9. Francis A, Sarkar S, Pooja S, Surekha D, Rao DR, Rao L, Ramachandra L, Vishnupriya S, Satyamoorthy K, Thangaraj K, Rajender S. SRD5A2 gene polymorphisms affect the risk of breast cancer. Breast 2013;23:137-141. Epub 2013 Dec 22 10. Quin K. Genetic Defect of Androgen Resistance. In: Weiss RE, Refetoff S (eds). Genetic Diagnosis of Endocrine Disorders. London, Elsevier, 2010:245-249
  7. Di Marco C, Bulotta AL, Varetti C, Dosa L, Michelucci A, Baldinotti F, Meucci D, Castagnini C, Lo Rizzo C, Di Maggio G, Simi P, Mari F, Bertelloni S, Renieri A, Messina M. Ambiguous external genitalia due to defect of 5-α-reductase in seven Iraqi patients: prevalence of a novel mutation. Gene 2013;526:490-493. Epub 2013 May 8 12. Savas Erdeve S, Aycan Z, Berberoglu M, Siklar Z, Hacihamdioglu B, Sipahi K, Akar N, Ocal G. A novel mutation of 5alpha-steroid reductase 2 deficiency (CD 65 ALA-PRO) with severe virilization defect in a Turkish family and difficulty in